Subscribe to RSS
DOI: 10.1055/s-2006-947189
Diterpenes from ”Pini Resina” and their Preferential Cytotoxic Activity under Nutrient-Deprived Condition
Dr. Prof. Shigetoshi Kadota
Institute of Natural Medicine
University of Toyama
2630 Sugitani
Toyama 930-0194
Japan
Phone: +81-76-434-7625
Fax: +81-76-434-5059
Email: kadota@ms.toyama-mpu.ac.jp
Publication History
Received: March 12, 2006
Accepted: June 1, 2006
Publication Date:
10 August 2006 (online)
Abstract
In the course of our search for anticancer agents based on a novel anti-austerity strategy, we found that the 70 % EtOH extract of ”Pini Resina” showed 100 % preferential cytotoxicity at the concentration of 50 μg/mL. Further bioassay-guided fractionation and purification led to the isolation of 15 compounds including one new compound 7-oxo-13α-hydroxyabiet-8(14)-en-18-oic acid (1). Their structures were elucidated on the basis of spectroscopic analysis. Among the isolated compounds, methyl abieta-8,11,13-trien-18-oate (7) showed the most potent preferential cytotoxicity at 10 μg/mL under nutrient-deprived condition.
Pancreatic cancer is an aggressive disease with the lowest survival rate of all cancers at 5 years [1], [2]. It is largely resistant to conventional forms of treatment and the development of more effective treatment is urgently needed. Previously, we reported that certain pancreatic cancer cell lines such as PANC-1, AsPC-1, BxPC-1, and KP-3 showed remarkable tolerance against extreme nutrient starvation [3] and the elimination of this tolerance of cancer cells to nutrient starvation might serve as a novel approach for cancer therapy [3], [4], [5], [6]. In this regard, we screened 500 medicinal plant extracts used in Japanese ”Kampo” medicine for their preferential cytotoxicity against PANC-1 cancer cells under nutrient-deprived conditions. Among them, the 70 % EtOH extract of ”Pini Resina” showed 100 % cytotoxicity preferentially in nutrient-deprived medium (NDM) at the concentration of 50 μg/mL. Thus, bioassay-guided fractionation and isolation of an active compound were carried out.
”Pini Resina” or ”Pine Resin” is the natural resin obtained from conifers and is commercially produced from about 20 pine species in many developing countries [7]. Traditionally, ”Pine Resin” has been used to resolve inflammations, to relieve the symptoms of cough, and to treat urinary problems [8], [9]. In Japanese ”Kampo” medicine, ”Pini Resina” is used for the treatment of skin diseases, diabetes, and tuberculosis and as a pain killer [10]. In the present study, bioassay-guided fractionation and purification led to the isolation of 15 compounds including one new compound 7-oxo-13α-hydroxyabiet-8(14)-en-18-oic acid (1).
”Pini Resina” was extracted with 70 % EtOH and the EtOH extract was chromatographed on silica gel with a MeOH/CHCl3 solvent system to give nine fractions. These fractions were examined for their preferential cytotoxic activity in NDM and the fractions 2 - 4 showed preferential cytotoxicity at 50 μg/mL. Thus, they were further separated to afford 15 diterpenes (1 - 15). The structures of known compounds were determined by comparisons of their spectral data with those in literature and were found to be 13,14-seco-13-oxoabiet-7-ene-14,18-dioic acid (2) [11], 8(14),15-pimaradien-18-oic acid (3) [12], 7-oxodehydroabietic acid (4) [13], 7-oxo-13β-hydroxyabiet-8(14)-en-18-oic acid (5) [14], methyl 7-oxoabieta-8,11,13-trien-18-oate (6) [15], methyl abieta-8,11,13-trien-18-oate (7) [16], 8(14)-podocarpen-7,13-dion-18-oic acid (8) [17], 8(14)-podocarpen-13-on-18-oic acid (9) [17], 12-hydroxydehydroabietic acid (10) [18], 13,14-seco-13,14-dioxoabiet-7-en-18-oic acid (11) [19], 8,11,13-abietatrien-18-oic acid (12) [16], 16-nor-15-oxodehydroabietic acid (13) [20], 8(14),15-pimaradien-18-ol (14) [12], and 12-oxoabieta-7,13-dien-18-oic acid (15) [21].
Compound 1 was isolated as colorless amorphous solid with [α]D 22: -27° (CHCl3) and its molecular formula was determined to be C20H30O4 by high resolution (HR)-EI-MS. The IR spectrum showed the presence of hydroxy (3600 cm-1) and carbonyl (1690 cm-1) groups. The 1H-NMR spectrum of 1 displayed signals due to two tertiary methyls, two secondary methyls, six methylenes, an isolated olefinic proton, and three aliphatic methines (Table [1]). On the other hand, the 13C-NMR spectrum showed the signals of 20 carbons including those of a ketone carbonyl carbon (δ C = 199.8), two olefinic carbons, and one oxygenated and two aliphatic quaternary carbons (Table [1]). These 1H- and 13C-NMR spectral data, and its molecular formula, were similar to those of the known compound 7-oxo-13β-hydroxyabiet-8(14)-en-18-oic acid (5) [14], isolated from the same extract, except for the slight difference in the chemical shift values in their 1H- and 13C-NMR spectra. Analysis of the 1H-1H COSY, HMQC, and HMBC spectra (Fig. [1] A) of 1 gave the same planar structure as 5, suggesting that 1 is a stereoisomer of 5. Furthermore, in the ROESY experiment, the correlations H3-19/H3-20, H-6β/H3-20, H-6β/H3-19, H-5/H-9, and H-1/H-9 (Fig. [1] B) indicated rings A and B to be trans-fused, with β-axial orientations of the C-19 and C-20 methyl groups, and α-axial orientations of H-5 and H-9, which is identical to the known compound 5. Thus, 1 and 5 should differ in the stereochemistry at C-13; i. e., the hydroxy group at C-13 in 1 should be α-oriented. As for ring C, the NOE enhancements between H3-20 and H-12β (δ = 1.41), H3-16 and H-12α (δ = 2.16), H3-17 and H-12α, H-9 and H-11α (δ = 1.39), H3-16 and H-14, H3-17 and H-14 were observed. The low-field shift of H-9 in 1 (δ H = 2.22) compared to that in 5 (δ H = 2.02) might be attributable to anisotropic deshielding by the α-oriented hydroxy group at C-13. From these data, 1 was determined to be 7-oxo-13α-hydroxyabiet-8(14)-en-18-oic acid.
Compound 2 was isolated as a colorless amorphous solid and a literature survey on 2 suggested it to be 13,14-seco-13-oxoabiet-7-en-14,18-dioic acid, previously reported as a semisynthetic reaction product of abietic acid [11]. In our present investigation, we isolated 2 as a natural product for the first time and assigned its 1H- and 13C-NMR data (Table [1]) based on 1H-1H COSY, HMQC and HMBC spectral data.
The isolated compounds were tested for their preferential cytotoxic activity under nutrient deprived condition. Preferential cytotoxicity is defined as the death of cancer cells selectively in nutrient-deprived medium (NDM) with no cytotoxicity in ordinary nutrient-rich medium (DMEM) [4], [5], [6]. Among the tested diterpenes, compound 7 exhibited the most potent preferential cytotoxic activity at 10 μg/mL (Fig. [2]). Compound 3, 6, 12, 13, and 14 showed moderate preferential cytotoxicity at 50 μg/mL while 4, 5, 8, 10 and 11 exhibited weak preferential cytotoxicity at 200 μg/mL. Compounds 1 and 2 were inactive at the maximum concentration tested, i. e., >200 μg/mL (Fig. [1]S in the Supporting Information). From the observed activity data, it can be concluded that esterification of the C-18 carboxyl group significantly enhances the activity (7 > 12). Esterification of the acid group, basically, renders the compound less polar, which could be responsible for the better penetration of the compound across the lipid bilayer surrounding the cells. All the tested diterpenes with a ketone group at C-7 showed weaker activity than the corresponding C-7 methylene compound (6 < 7, 4 < 12, 8 < 9). Additionally, the hydroxy group at C-12 also decreased the activity (10 < 12). As compound 7 was an extremely minor compound, the observed cytotoxic activity in ”Pini Resina” extract might be attributable to the major compounds such as 3 and 12.


Fig. 1 Connectivities (bold lines) deduced by the COSY and HMQC spectra and key HMBC correlations (arrows) (A), and ROESY correlations (arrows) and selected NOEs (dashed arrows) (B) observed for 1.
Position | 1 | 2 | ||
δH | δC | δH | δC | |
1 | 1.24 m | 37.4 | 1.10 m | 38.3 |
1.77 m | 1.93 m | |||
2 | 1.64 m | 17.7 | 1.57 m | 17.6 |
3 | 1.77 m | 36.1 | 1.70 m | 36.5 |
4 | 46.0 | 45.8 | ||
5 | 2.38 m | 44.8 | 1.98 m | 43.9 |
6 | 2.37 m | 38.9 | 1.96 m | 25.6 |
2.14 m | ||||
7 | 199.8 | 6.82 br s | 139.8 | |
8 | 136.8 | 134.5 | ||
9 | 2.22 m | 50.7 | 2.14 m | 50.2 |
10 | 35.8 | 36.8 | ||
11 | α 1.39 m | 20.5 | 1.47 m | 21.7 |
β 1.78 m | 1.90 m | |||
12 | α 2.16 m | 32.8 | 2.43 ddd (17.0, 11.0, 5.4) |
40.7 |
β 1.41 m | 2.84 ddd (17.0, 11.0, 6.6) |
|||
13 | 72.5 | 215.2 | ||
14 | 6.74 s | 141.4 | 173.5 | |
15 | 1.79 m | 36.7 | 2.57 septet (6.8) | 40.7 |
16 | 0.94 d (6.8) | 16.7 | 1.06 d (6.8) | 18.2 |
17 | 0.97 d (6.8) | 16.9 | 1.07 d (6.8) | 18.2 |
18 | 182.0 | 184.0 | ||
19 | 1.24 s | 16.1 | 1.24 s | 16.9 |
20 | 0.86 s | 14.1 | 0.86 s | 14.5 |

Fig. 2 Effect of compound 7 on the survival of PANC-1 cells in NDM (-•-) and DMEM (-▴-). Each point represents the mean of triplicates of experiments.
Materials and Methods
Optical rotations were recorded on a JASCO DIP-140 digital polarimeter. IR spectra were measured with a Shimadzu IR-408 spectrophotometer in CHCl3 solution. NMR spectra were taken on a JEOL JNM-LA400 spectrometer in CDCl3 solution with tetramethylsilane (TMS) as an internal standard, and chemical shifts are expressed in δ values. HR-EI-MS measurements were carried out on a JEOL JMS-700T spectrometer. Column chromatography was performed with BW-820MH silica gel (Fuji Silysia; Aichi, Japan). Analytical and preparative TLC were carried out on precoated silica gel 60F254 or RP-18F254 plates (Merck; Darmstadt, Germany; 0.25 or 0.50 mm thickness).
Commercial ”Pini Resina” imported from China was purchased from Alps Pharmaceutical Company (Gifu, Japan).
”Pini Resina” (90.0 g) was extracted with 70 % EtOH-H2O (3 L, 24 h × 3) at room temperature to give 87.0 g of extract which was subjected to silica gel column chromatography (7 × 40 cm) with a MeOH/CHCl3 (0 - 50 %) gradient system to give nine fractions: Fr. 1 (0.1 g), CHCl3 eluate (1 L); Fr. 2 (14.2 g), CHCl3 eluate (4 L); Fr. 3 (6.3 g), 5 % MeOH-CHCl3 eluate (2 L); Fr. 4 (5.1 g), 8 % MeOH-CHCl3 eluate (2 L); Fr. 5 (6.3 g), 10 % MeOH-CHCl3 eluate (2 L); Fr. 6 (6.8 g), 15 % MeOH-CHCl3 eluate (2 L); Fr. 7 (10.1 g), 20 % MeOH-CHCl3 eluate (2.5 L); Fr. 8 (12.5 g), 30 % MeOH-CHCl3 eluate (3 L); and Fr. 9 (18.2 g), 50 % MeOH-CHCl3 eluate (3 L).
Fr. 2 was rechromatographed (4 × 30 cm) on silica gel with MeOH/CH2Cl2 (0 - 50 %), and the subfractions obtained were further separated by reversed-phase preparative TLC with MeCN/acetone/H2O (1 : 1:1), to give the following compounds: 1 (2.3 mg, Rf = 0.52), 2 (4.5 mg, Rf = 0.65), 3 (2.03 g, Rf = 0.14), 4 (20.0 mg, Rf = 0.40), 5 (5.0 mg, Rf = 0.60), 6 (3.4 mg, Rf = 0.16), 7 (2.0 mg, Rf = 0.09), 8 (10.2 mg, Rf = 0.56), 9 (6.5 mg, Rf = 0.62), 10 (10.3 mg, Rf = 0.44), 11 (100 mg, Rf = 0.46), 12 (20.6 mg, Rf = 0.20), and 13 (6.0 mg, Rf = 0.43).
Fr.3 (6.0 g) was subjected to column chromatography (3 × 35 cm) using a MeOH/CHCl3 (0 - 30 %) gradient system to afford five subfractions 1 - 5. Subfraction 3 - 2 yielded 3 (0.5 g), 12 (1.12 g), and 14 (5.0 mg, Rf = 0.31) by reversed-phase preparative TLC with MeCN/acetone/H2O (1 : 1:1).
Fr.4 (5.0 g) was also subjected to silica gel column chromatography (3 × 35 cm) with EtOAc/hexane and then MeOH/CHCl3 to give five subfractions 1 - 5. Purification of fr.4 - 4 by reversed-phase preparative TLC with MeCN/acetone/H2O (1 : 1:1) yielded 3 (30.5), 12 (50.4 mg), and 15 (10.0 mg, Rf = 0.36).
7-Oxo-13α-hydroxyabiet-8(14)-en-18-oic acid (1): Colorless amorphous solid; [α]D 22: -27° (c 0.14 CHCl3); IR (CHCl3): νmax = 3600, 1690, 1460, 1390 cm-1; 1H- and 13C-NMR see Table [1]; HR-EI-MS: m/z = [M+] 334.2148 (calcd for C20H30O4: 334.2144).
13,14-Seco-13-oxoabiet-7-en-14,18-dioic acid (2): Colorless amorphous solid; [α]D 24: -6° (c 0.3 CHCl3); IR (CHCl3): νmax = 1710, 1700, 1690, 1460, 1270 cm-1; 1H- and 13C-NMR see Table [1]; HR-EI-MS: m/z = [M+] 350.2110 (calcd for C20H30O5: 350.2093).
PANC-1 preferential cytotoxicity assay was done as described earlier [3] and is provided in the Supporting Information. Briefly, PANC-1 cancer cells were seeded in 96-well plates (1 × 104/well) and incubated in fresh Dulbecco’s modified Eagle’s medium (DMEM; Nissui Pharmaceuticals; Tokyo, Japan) at 37 °C under 5 % CO2 and 95 % air for 24 h. The nutrient-deprived medium (NDM) was prepared following the procedure described by Esumi et al [3]. After the cells were washed with PBS (Nissui Pharmaceuticals), the medium was changed to either DMEM or NDM and serial dilutions of the test samples were added. After 24 h incubation, the cells were washed with PBS, and 100 μL of DMEM containing 10 % WST-8 cell counting kit (Dojindo; Kumamoto, Japan) solution was added to the wells. After 2 h incubation, absorbance at 450 nm was measured. Cell viability was calculated from the mean values of data from three wells.
Cell viability (%) =
[{Abs(test sample) - Abs(blank)}/{Abs(control) - Abs(blank)}] × 100
Acknowledgements
This work was supported in part by a grant from the Ministry of Health and Welfare for the Second-Term Comprehensive 10-year Strategy for Cancer Control, Grants-in-Aid for Cancer Research from the Ministry of Health and Welfare and grant from the Ministry of Education, Culture, Sports, Science and Technology.
- Supporting Information for this article is available online at
- Supporting Information .
References
- 1 Li D, Xie K, Wolff R, Abbruzzese J L. Pancreatic cancer. Lancet. 2004; 363 1049-57
- 2 Shore S, Vimalachandran D, Raraty M GT, Ghaneh P. Cancer in the elderly: pancreatic cancer. Surg Oncol. 2004; 13 201-10
- 3 Izushi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 2000; 60 6201-7
- 4 Awale S, Lu J, Kalauni S K, Kurashima Y, Tezuka Y, Kadota S. et al . Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 2006; 66 1751-7
- 5 Awale S, Nakashima E MN, Kalauni S K, Tezuka Y, Kurashima Y, Lu J. et al . Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. Bioorg Med Chem Lett. 2006; 16 581-3
- 6 Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H. Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells’ tolerance to nutrient starvation. Cancer Sci. 2004; 95 547-52
- 7 Zinkel D, Russel J. Naval stores: production, chemistry, utilization. In: Zinkel D, Russel J, editors Atlanta; Pine Chemicals Association 1989
- 8 Usmanghani K, Saeed A, Alam M T. Indusynic Medicine. In: Usmanghani K, editor 1st edition A-952. Karachi; Research Institute of Indusyunic Medicine 1997: p 338-9
- 9 William M C. Non-wood forest products from conifers. Rome; FAO-Food and Agriculture Organization of the United Nations 1995: p 1-15
- 10 Namba T. Coloured illustrations of Wakan-Yaku (The crude drugs in Japan, China and the neighbouring countries). In: Namba T, editor Vol II Osaka; Hoikusha Publishing Co, Ltd 1980: p 24-5
- 11 Ruzicka L, Sternbach L. Zur Kenntnis der Diterpene. Helv Chim Acta. 1940; 23 341-55
- 12 Darling T R, Turro N J. Carbon-13 nuclear magnetic resonances spectroscopy of naturally occurring substances. X. Pimaradienes. J Am Chem Soc. 1972; 94 4367-9
- 13 Ayer W A, Macaulay J B. Metabolites of the honey mushroom, Armillaria mellea . Can J Chem. 1987; 65 7-13
- 14 Bol’shakova V I, Shmidt E N, Pentegova V A, Mamatyuk V I. Minor constituents of the resin of the Kurile Dahurian, Japanese and Siberian larches. Khim Prir Soedin. 1986; 5 571-6
- 15 Erdtman H, Malmborg L. The Beckmann rearrangement of the oxime of 7-ketodehydroabietate. A side reaction. Acta Chem Scand. 1970; 24 2252
- 16 Chamy M C, Piovano M, Gambaro V, Garbarino J A, Nicoletti M. Dehydroabietane diterpenoids from Calceolaria ascendens . Phytochemistry. 1987; 26 1763-5
- 17 Cheung H TA, Miyase T, Lenguyen M P, Smal M A. Further acidic and neutral components of Pinus massoniana Resin. Tetrahedron. 1993; 49 7903-15
- 18 Kinouchi Y, Ohtsu H, Tokuda H, Nishino H, Matsunaga S, Tanaka R. Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni . J Nat Prod. 2000; 63 817-20
- 19 Ohtsu H, Tanaka R, In Y, Matsunaga S, Tokuda H, Nishino H. Abietane diterpenoids from the cones of Larix kaempferi and their inhibitory effects on Epstein-Barr virus activation. Planta Med. 2001; 67 55-60
- 20 Tanaka R, Ohtsu H, Matsunaga S. Abietane diterpene acids and other constituents from the leaves of Larix kaempferi . Phytochemistry. 1997; 46 1051-7
- 21 Roshchin V I, Kolodynskaya L A, Raldugin V A. Abietic and dehydroabietic acid derivatives from the needle-free shoots of Pinus sylvestris . Khim Prir Soedin. 1985; 3 345-51
Dr. Prof. Shigetoshi Kadota
Institute of Natural Medicine
University of Toyama
2630 Sugitani
Toyama 930-0194
Japan
Phone: +81-76-434-7625
Fax: +81-76-434-5059
Email: kadota@ms.toyama-mpu.ac.jp
References
- 1 Li D, Xie K, Wolff R, Abbruzzese J L. Pancreatic cancer. Lancet. 2004; 363 1049-57
- 2 Shore S, Vimalachandran D, Raraty M GT, Ghaneh P. Cancer in the elderly: pancreatic cancer. Surg Oncol. 2004; 13 201-10
- 3 Izushi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 2000; 60 6201-7
- 4 Awale S, Lu J, Kalauni S K, Kurashima Y, Tezuka Y, Kadota S. et al . Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 2006; 66 1751-7
- 5 Awale S, Nakashima E MN, Kalauni S K, Tezuka Y, Kurashima Y, Lu J. et al . Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. Bioorg Med Chem Lett. 2006; 16 581-3
- 6 Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H. Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells’ tolerance to nutrient starvation. Cancer Sci. 2004; 95 547-52
- 7 Zinkel D, Russel J. Naval stores: production, chemistry, utilization. In: Zinkel D, Russel J, editors Atlanta; Pine Chemicals Association 1989
- 8 Usmanghani K, Saeed A, Alam M T. Indusynic Medicine. In: Usmanghani K, editor 1st edition A-952. Karachi; Research Institute of Indusyunic Medicine 1997: p 338-9
- 9 William M C. Non-wood forest products from conifers. Rome; FAO-Food and Agriculture Organization of the United Nations 1995: p 1-15
- 10 Namba T. Coloured illustrations of Wakan-Yaku (The crude drugs in Japan, China and the neighbouring countries). In: Namba T, editor Vol II Osaka; Hoikusha Publishing Co, Ltd 1980: p 24-5
- 11 Ruzicka L, Sternbach L. Zur Kenntnis der Diterpene. Helv Chim Acta. 1940; 23 341-55
- 12 Darling T R, Turro N J. Carbon-13 nuclear magnetic resonances spectroscopy of naturally occurring substances. X. Pimaradienes. J Am Chem Soc. 1972; 94 4367-9
- 13 Ayer W A, Macaulay J B. Metabolites of the honey mushroom, Armillaria mellea . Can J Chem. 1987; 65 7-13
- 14 Bol’shakova V I, Shmidt E N, Pentegova V A, Mamatyuk V I. Minor constituents of the resin of the Kurile Dahurian, Japanese and Siberian larches. Khim Prir Soedin. 1986; 5 571-6
- 15 Erdtman H, Malmborg L. The Beckmann rearrangement of the oxime of 7-ketodehydroabietate. A side reaction. Acta Chem Scand. 1970; 24 2252
- 16 Chamy M C, Piovano M, Gambaro V, Garbarino J A, Nicoletti M. Dehydroabietane diterpenoids from Calceolaria ascendens . Phytochemistry. 1987; 26 1763-5
- 17 Cheung H TA, Miyase T, Lenguyen M P, Smal M A. Further acidic and neutral components of Pinus massoniana Resin. Tetrahedron. 1993; 49 7903-15
- 18 Kinouchi Y, Ohtsu H, Tokuda H, Nishino H, Matsunaga S, Tanaka R. Potential antitumor-promoting diterpenoids from the stem bark of Picea glehni . J Nat Prod. 2000; 63 817-20
- 19 Ohtsu H, Tanaka R, In Y, Matsunaga S, Tokuda H, Nishino H. Abietane diterpenoids from the cones of Larix kaempferi and their inhibitory effects on Epstein-Barr virus activation. Planta Med. 2001; 67 55-60
- 20 Tanaka R, Ohtsu H, Matsunaga S. Abietane diterpene acids and other constituents from the leaves of Larix kaempferi . Phytochemistry. 1997; 46 1051-7
- 21 Roshchin V I, Kolodynskaya L A, Raldugin V A. Abietic and dehydroabietic acid derivatives from the needle-free shoots of Pinus sylvestris . Khim Prir Soedin. 1985; 3 345-51
Dr. Prof. Shigetoshi Kadota
Institute of Natural Medicine
University of Toyama
2630 Sugitani
Toyama 930-0194
Japan
Phone: +81-76-434-7625
Fax: +81-76-434-5059
Email: kadota@ms.toyama-mpu.ac.jp


Fig. 1 Connectivities (bold lines) deduced by the COSY and HMQC spectra and key HMBC correlations (arrows) (A), and ROESY correlations (arrows) and selected NOEs (dashed arrows) (B) observed for 1.

Fig. 2 Effect of compound 7 on the survival of PANC-1 cells in NDM (-•-) and DMEM (-▴-). Each point represents the mean of triplicates of experiments.
- www.thieme-connect.de/ejournals/toc/plantamedica